{
  "doc_id": "2_nutritionalrequirements_part2__0426f0",
  "original_filename": "2_NutritionalRequirements,Part2.pdf",
  "md_path": "data/parsed/2_NutritionalRequirements,Part2/2_NutritionalRequirements,Part2.md",
  "rmd_path": "data/parsed/2_NutritionalRequirements,Part2/2_NutritionalRequirements,Part2.rmd",
  "blocks": [
    {
      "type": "heading",
      "level": 1,
      "section": "NUTRITION SUPPORT CERTIFICATE",
      "line": 0
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Nutritional",
      "line": 2
    },
    {
      "type": "text",
      "section": "Nutritional",
      "line": 4,
      "preview": "Requirements, Part 2"
    },
    {
      "type": "image",
      "section": "Nutritional",
      "line": 5,
      "content": "![img-0.jpeg](images/9c01a79eee8ab186.png)"
    },
    {
      "type": "text",
      "section": "Nutritional",
      "line": 7,
      "preview": "Planned by the American Society of Health-System Pharmacists (ASHP) in collaboration with the Americ"
    },
    {
      "type": "text",
      "section": "Nutritional",
      "line": 8,
      "preview": "\u00a92022 American Society of Health-System Pharmacists, Inc. All rights reserved."
    },
    {
      "type": "text",
      "section": "Nutritional",
      "line": 9,
      "preview": "No part of this publication may be reproduced or transmitted in any form or by any means, electronic"
    },
    {
      "type": "text",
      "section": "Nutritional",
      "line": 11,
      "preview": "--- page 1 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "NUTRITIONAL REQUIREMENTS",
      "line": 13
    },
    {
      "type": "text",
      "section": "NUTRITIONAL REQUIREMENTS",
      "line": 15,
      "preview": "PART 2"
    },
    {
      "type": "text",
      "section": "NUTRITIONAL REQUIREMENTS",
      "line": 16,
      "preview": "Todd W. Canada, Pharm.D., BCNSP, BCCCP, FASHP, FTSHP, FASPEN"
    },
    {
      "type": "text",
      "section": "NUTRITIONAL REQUIREMENTS",
      "line": 17,
      "preview": "University of Texas MD Anderson"
    },
    {
      "type": "text",
      "section": "NUTRITIONAL REQUIREMENTS",
      "line": 18,
      "preview": "Cancer Center"
    },
    {
      "type": "text",
      "section": "NUTRITIONAL REQUIREMENTS",
      "line": 20,
      "preview": "NUTRITION SUPPORT CERTIFICATE"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 22
    },
    {
      "type": "image",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 24,
      "content": "![img-1.jpeg](images/95661183b74a919d.png)"
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 26,
      "preview": "No one in control of the content of this activity has a relevant financial relationship (RFR) with a"
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 28,
      "preview": "As defined by the Standards of Integrity and Independence in Accredited Continuing Education definit"
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 30,
      "preview": "--- page 2 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "LEARNING OBJECTIVES",
      "line": 32
    },
    {
      "type": "text",
      "section": "LEARNING OBJECTIVES",
      "line": 34,
      "preview": "- Assess the electrolyte content of an initial parenteral nutrition formulation."
    },
    {
      "type": "text",
      "section": "LEARNING OBJECTIVES",
      "line": 35,
      "preview": "- Recommend appropriate electrolyte content adjustments in a parenteral nutrition order, based on a "
    },
    {
      "type": "text",
      "section": "LEARNING OBJECTIVES",
      "line": 36,
      "preview": "- Discuss the importance of providing the full dose of intravenous multivitamin daily in parenteral "
    },
    {
      "type": "text",
      "section": "LEARNING OBJECTIVES",
      "line": 37,
      "preview": "- Evaluate the trace element content of a parenteral nutrition formulation."
    },
    {
      "type": "text",
      "section": "LEARNING OBJECTIVES",
      "line": 38,
      "preview": "- Discuss the assessment timeline and potential consequences for continuing \"empiric\" additions or d"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "KEY ABBREVIATIONS",
      "line": 41
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 43,
      "preview": "- AA:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 44,
      "preview": "- ABW:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 45,
      "preview": "- ALA:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 46,
      "preview": "- CrCl :"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 47,
      "preview": "- Dex:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 48,
      "preview": "- EFA:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 49,
      "preview": "- EFAD:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 50,
      "preview": "- EN:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 51,
      "preview": "- Gl:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 52,
      "preview": "- IBW:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 53,
      "preview": "amino acids"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 54,
      "preview": "adjusted body weight"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 55,
      "preview": "alpha-linolenic acid"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 56,
      "preview": "creatinine clearance"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 57,
      "preview": "Dextrose"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 58,
      "preview": "essential fatty acids"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 59,
      "preview": "essential fatty acid deficiency"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 60,
      "preview": "enteral nutrition"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 61,
      "preview": "gastrointestinal"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 62,
      "preview": "ideal body weight"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 64,
      "preview": "--- page 3 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 66
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 68,
      "preview": "- ILE: lipid injectable emulsion"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 69,
      "preview": "- IV: intravenous"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 70,
      "preview": "- LA: linoleic acid"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 71,
      "preview": "- MCT: medium chain triglycerides"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 72,
      "preview": "- NPO: nil per os (nothing by mouth)"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 73,
      "preview": "- PN: parenteral nutrition"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 74,
      "preview": "- CRRT: continuous renal replacement therapy"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 75,
      "preview": "- TBW: total body water"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF-ASSESSMENT \\#1",
      "line": 78
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 80,
      "preview": "RC is a malnourished 52-year-old male with a postoperative ileus on hospital day 3. His nasogastric "
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 81,
      "preview": "A. Sodium, Phosphorus and Calcium"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 82,
      "preview": "B. Sodium and Potassium only"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 83,
      "preview": "C. Potassium and Magnesium only"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 84,
      "preview": "D. Potassium, Phosphorus and Magnesium"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 86,
      "preview": "--- page 4 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "PATIENT SPECIFIC ELECTROLYTE CONSIDERATIONS",
      "line": 88
    },
    {
      "type": "text",
      "section": "PATIENT SPECIFIC ELECTROLYTE CONSIDERATIONS",
      "line": 90,
      "preview": "- Evaluate all measurable electrolytes"
    },
    {
      "type": "text",
      "section": "PATIENT SPECIFIC ELECTROLYTE CONSIDERATIONS",
      "line": 91,
      "preview": "- Rarely is there only one electrolyte abnormality"
    },
    {
      "type": "text",
      "section": "PATIENT SPECIFIC ELECTROLYTE CONSIDERATIONS",
      "line": 92,
      "preview": "- Evaluate patient's renal (blood urea nitrogen, serum creatinine) \\& GI function"
    },
    {
      "type": "text",
      "section": "PATIENT SPECIFIC ELECTROLYTE CONSIDERATIONS",
      "line": 93,
      "preview": "- What is their urine output?"
    },
    {
      "type": "text",
      "section": "PATIENT SPECIFIC ELECTROLYTE CONSIDERATIONS",
      "line": 94,
      "preview": "- Normally $0.5-2 \\mathrm{~mL} / \\mathrm{kg} / \\mathrm{hr}$"
    },
    {
      "type": "text",
      "section": "PATIENT SPECIFIC ELECTROLYTE CONSIDERATIONS",
      "line": 95,
      "preview": "- What is their GI anatomy?"
    },
    {
      "type": "text",
      "section": "PATIENT SPECIFIC ELECTROLYTE CONSIDERATIONS",
      "line": 96,
      "preview": "- Prior surgeries or medical history"
    },
    {
      "type": "text",
      "section": "PATIENT SPECIFIC ELECTROLYTE CONSIDERATIONS",
      "line": 97,
      "preview": "- Evaluate medications for drug-nutrient interactions"
    },
    {
      "type": "text",
      "section": "PATIENT SPECIFIC ELECTROLYTE CONSIDERATIONS",
      "line": 99,
      "preview": "Canada TW et al. ASPEN Adult Nutrition Support Core Curriculum. 3rd ed. 2017:113-37."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "ELECTROLYTE REPLACEMENT CONSIDERATIONS",
      "line": 101
    },
    {
      "type": "text",
      "section": "ELECTROLYTE REPLACEMENT CONSIDERATIONS",
      "line": 103,
      "preview": "- Most abnormal electrolytes need to be corrected over a chronic period"
    },
    {
      "type": "text",
      "section": "ELECTROLYTE REPLACEMENT CONSIDERATIONS",
      "line": 104,
      "preview": "- 3 to 7 days in most patients to replace total body stores"
    },
    {
      "type": "text",
      "section": "ELECTROLYTE REPLACEMENT CONSIDERATIONS",
      "line": 105,
      "preview": "- Substantial portions ( $>50 \\%$ ) of the electrolyte may be lost in the urine"
    },
    {
      "type": "text",
      "section": "ELECTROLYTE REPLACEMENT CONSIDERATIONS",
      "line": 106,
      "preview": "- Serum concentrations approximate renal threshold"
    },
    {
      "type": "text",
      "section": "ELECTROLYTE REPLACEMENT CONSIDERATIONS",
      "line": 107,
      "preview": "- Infusion may exceed the renal reabsorption threshold of the electrolyte"
    },
    {
      "type": "text",
      "section": "ELECTROLYTE REPLACEMENT CONSIDERATIONS",
      "line": 108,
      "preview": "- Most are approximately 90-99\\% reabsorbed by kidney"
    },
    {
      "type": "text",
      "section": "ELECTROLYTE REPLACEMENT CONSIDERATIONS",
      "line": 110,
      "preview": "--- page 5 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "CORRECTING ELECTROLYTE DISORDERS",
      "line": 112
    },
    {
      "type": "image",
      "section": "CORRECTING ELECTROLYTE DISORDERS",
      "line": 114,
      "content": "![img-2.jpeg](images/4f56eb7ebda1a0dd.png)"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "LAG TIME BETWEEN LAB DRAWS AND INITIATION OF PN INPATIENT",
      "line": 116
    },
    {
      "type": "image",
      "section": "LAG TIME BETWEEN LAB DRAWS AND INITIATION OF PN INPATIENT",
      "line": 118,
      "content": "![img-3.jpeg](images/09f4109c6384fe18.png)"
    },
    {
      "type": "text",
      "section": "LAG TIME BETWEEN LAB DRAWS AND INITIATION OF PN INPATIENT",
      "line": 120,
      "preview": "--- page 6 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "CORRECTING ELECTROLYTE DISORDERS",
      "line": 122
    },
    {
      "type": "image",
      "section": "CORRECTING ELECTROLYTE DISORDERS",
      "line": 124,
      "content": "![img-4.jpeg](images/13d1966887faa978.png)"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "DETERMINING ELECTROLYTE NEEDS",
      "line": 126
    },
    {
      "type": "image",
      "section": "DETERMINING ELECTROLYTE NEEDS",
      "line": 128,
      "content": "![img-5.jpeg](images/0f112e7542ef57b2.png)"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS",
      "line": 130,
      "preview": "| Electrolyte | Standard Daily <br> Requirement | Factors Increasing <br> Daily Requirement | Salts "
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS",
      "line": 131,
      "preview": "| :--: | :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS",
      "line": 132,
      "preview": "| Sodium | $1-2 \\mathrm{mEq} / \\mathrm{kg}^{*}$ | Diarrhea, vomiting, <br> nasogastric or Gl <br> lo"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS",
      "line": 133,
      "preview": "| Potassium | $1-2 \\mathrm{mEq} / \\mathrm{kg}^{*}$ | Diarrhea, vomiting, <br> nasogastric or Gl <br>"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS",
      "line": 135,
      "preview": "* Multiple salts may be used to meet dosage"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS",
      "line": 137,
      "preview": "--- page 7 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 139
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 141,
      "preview": "|  Electrolyte | Standard Daily"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 142,
      "preview": "Requirement | Factors Increasing"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 143,
      "preview": "Daily Requirement | Salts Available | Therapeutic"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 144,
      "preview": "Index  |"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 145,
      "preview": "| --- | --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 146,
      "preview": "|  Chloride | As needed to"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 147,
      "preview": "maintain acid-base"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 148,
      "preview": "balance | Metabolic alkalosis,"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 149,
      "preview": "vomiting or nasogastric"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 150,
      "preview": "losses | NaCl, KCl,"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 151,
      "preview": "Magnesium"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 152,
      "preview": "chloride | Wide  |"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 153,
      "preview": "|  Acetate* | As needed to"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 154,
      "preview": "maintain acid-base"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 155,
      "preview": "balance | Acute/Chronic kidney"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 156,
      "preview": "disease, metabolic"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 157,
      "preview": "acidosis, ileostomy,"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 158,
      "preview": "diarrhea | NaAcetate,"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 159,
      "preview": "KAcetate | Wide  |"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 161,
      "preview": "- Liver function must be adequate to convert to bicarbonate"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 163,
      "preview": "*Mirtallo J et al. JPEN J Parent Enteral Nutr. 2004; 28:S39-S70.*"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 165
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 167,
      "preview": "|  Electrolyte | Standard Daily"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 168,
      "preview": "Requirement | Factors Increasing Daily"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 169,
      "preview": "Requirement | Salts Available | Therapeutic"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 170,
      "preview": "Index  |"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 171,
      "preview": "| --- | --- | --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 172,
      "preview": "|  Calcium | $10-15 \\mathrm{mEq}$ | Vitamin D deficiency,"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 173,
      "preview": "acute pancreatitis,"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 174,
      "preview": "parathyroidectomy | Calcium gluconate"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 175,
      "preview": "preferred | Narrow  |"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 176,
      "preview": "|  Magnesium | $8-20 \\mathrm{mEq}$ | Diarrhea, ileostomy,"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 177,
      "preview": "diuretics, diabetes"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 178,
      "preview": "mellitus, alcoholism,"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 179,
      "preview": "refractoryhypokalemia | Magnesium"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 180,
      "preview": "sulfate,"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 181,
      "preview": "Magnesium"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 182,
      "preview": "chloride | Wide  |"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 183,
      "preview": "|  Phosphate | $20-40 \\mathrm{mmol}^{\\star}$ | Insulin, dextrose"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 184,
      "preview": "administration, alcoholics,"
    },
    {
      "type": "table",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 185,
      "preview": "refeeding syndrome | $\\mathrm{NaPO}_{4}, \\mathrm{KPO}_{4}$ | Wide  |"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 187,
      "preview": "- Multiple salts may be used to meet dosage"
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 189,
      "preview": "Mirtallo J et al. JPEN J Parent Enteral Nutr. 2004; 28:S39-S70."
    },
    {
      "type": "text",
      "section": "DETERMINING ELECTROLYTE NEEDS, CONT.",
      "line": 191,
      "preview": "--- page 8 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "DIFFERENCES IN EN VS PN PROVISION",
      "line": 193
    },
    {
      "type": "text",
      "section": "DIFFERENCES IN EN VS PN PROVISION",
      "line": 195,
      "preview": "- What is the bioavailability of the specified route of administration?"
    },
    {
      "type": "text",
      "section": "DIFFERENCES IN EN VS PN PROVISION",
      "line": 196,
      "preview": "- Oral, nasogastric tube, nasojejunostomy tube"
    },
    {
      "type": "text",
      "section": "DIFFERENCES IN EN VS PN PROVISION",
      "line": 197,
      "preview": "- Dependent on rate of administration, tolerance"
    },
    {
      "type": "text",
      "section": "DIFFERENCES IN EN VS PN PROVISION",
      "line": 198,
      "preview": "- May be $<70 \\%$ with distention, ileus, diarrhea, vomiting, prior surgical resection(s) of small i"
    },
    {
      "type": "text",
      "section": "DIFFERENCES IN EN VS PN PROVISION",
      "line": 199,
      "preview": "- Absence of ileocecal valve results in increased colonic transit times"
    },
    {
      "type": "text",
      "section": "DIFFERENCES IN EN VS PN PROVISION",
      "line": 200,
      "preview": "- Central or Peripheral IV"
    },
    {
      "type": "text",
      "section": "DIFFERENCES IN EN VS PN PROVISION",
      "line": 201,
      "preview": "- 100\\% bioavailable as bypassing Gl tract"
    },
    {
      "type": "text",
      "section": "DIFFERENCES IN EN VS PN PROVISION",
      "line": 202,
      "preview": "- Is the rate of administration safe for electrolytes?"
    },
    {
      "type": "text",
      "section": "DIFFERENCES IN EN VS PN PROVISION",
      "line": 203,
      "preview": "- Oral is always safer than IV administration"
    },
    {
      "type": "text",
      "section": "DIFFERENCES IN EN VS PN PROVISION",
      "line": 204,
      "preview": "\u00bb If the Gl tract is functional"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF-ASSESSMENT \\#1",
      "line": 207
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 209,
      "preview": "RC is a malnourished 52-year-old male with a postoperative ileus on hospital day 3. His nasogastric "
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 210,
      "preview": "A. Sodium, Phosphorus and Calcium"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 211,
      "preview": "B. Sodium and Potassium only"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 212,
      "preview": "C. Potassium and Magnesium only"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 213,
      "preview": "D. Potassium, Phosphorus and Magnesium"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 215,
      "preview": "--- page 9 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF-ASSESSMENT \\#1",
      "line": 217
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 219,
      "preview": "RC is a malnourished 52-year-old male with a postoperative ileus on hospital day 3. His nasogastric "
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 220,
      "preview": "A. Sodium, Phosphorus and Calcium"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 221,
      "preview": "B. Sodium and Potassium only"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 222,
      "preview": "C. Potassium and Magnesium only"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 223,
      "preview": "D. Potassium, Phosphorus and Magnesium"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "VITAMIN REQUIREMENTS",
      "line": 225
    },
    {
      "type": "text",
      "section": "VITAMIN REQUIREMENTS",
      "line": 227,
      "preview": "- Multivitamins"
    },
    {
      "type": "text",
      "section": "VITAMIN REQUIREMENTS",
      "line": 228,
      "preview": "- Adult MVI"
    },
    {
      "type": "text",
      "section": "VITAMIN REQUIREMENTS",
      "line": 229,
      "preview": "- Daily requirement of 10 mL"
    },
    {
      "type": "text",
      "section": "VITAMIN REQUIREMENTS",
      "line": 230,
      "preview": "- During shortages reserve supply for long-term PN patients"
    },
    {
      "type": "text",
      "section": "VITAMIN REQUIREMENTS",
      "line": 231,
      "preview": "- Additional Thiamine 100 mg if no MVI supply"
    },
    {
      "type": "text",
      "section": "VITAMIN REQUIREMENTS",
      "line": 232,
      "preview": "- Thiamine is required to convert dextrose for use in the Krebs Cycle"
    },
    {
      "type": "text",
      "section": "VITAMIN REQUIREMENTS",
      "line": 233,
      "preview": "- In thiamine deficiency, dextrose leads to excessive production of lactate"
    },
    {
      "type": "text",
      "section": "VITAMIN REQUIREMENTS",
      "line": 235,
      "preview": "Mundi MS et al. JPEN J Parenter Enteral Nutr. 2017; 41(4):535-49."
    },
    {
      "type": "text",
      "section": "VITAMIN REQUIREMENTS",
      "line": 237,
      "preview": "--- page 10 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "MICRONUTRIENTS (TRACE ELEMENTS)",
      "line": 239
    },
    {
      "type": "table",
      "section": "MICRONUTRIENTS (TRACE ELEMENTS)",
      "line": 241,
      "preview": "| Trace Element | Standard Daily <br> Requirement | Factors Affecting Daily <br> Requirement | Long-"
    },
    {
      "type": "table",
      "section": "MICRONUTRIENTS (TRACE ELEMENTS)",
      "line": 242,
      "preview": "| :-- | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "MICRONUTRIENTS (TRACE ELEMENTS)",
      "line": 243,
      "preview": "| Zinc | $2.5-5 \\mathrm{mg}$ | Increased for diarrhea, Gl losses, <br> burns | No |"
    },
    {
      "type": "table",
      "section": "MICRONUTRIENTS (TRACE ELEMENTS)",
      "line": 244,
      "preview": "| Copper | $0.3-0.5 \\mathrm{mg}$ | Increasedfor burns or CRRT, <br> Reduce in severe hepatic <br> dy"
    },
    {
      "type": "table",
      "section": "MICRONUTRIENTS (TRACE ELEMENTS)",
      "line": 245,
      "preview": "| Selenium | $60-100 \\mathrm{mcg}$ | Increased for CRRT | No |"
    },
    {
      "type": "table",
      "section": "MICRONUTRIENTS (TRACE ELEMENTS)",
      "line": 246,
      "preview": "| Manganese | 55 mcg | Reduce in severe hepatic <br> dysfunction or cholestasis | Yes |"
    },
    {
      "type": "table",
      "section": "MICRONUTRIENTS (TRACE ELEMENTS)",
      "line": 247,
      "preview": "| Chromium | None | Common parenteral contaminant | Yes |"
    },
    {
      "type": "text",
      "section": "MICRONUTRIENTS (TRACE ELEMENTS)",
      "line": 249,
      "preview": "Mirtallo J et al. JPEN J ParentEnteral Nutr. 2004; 28:S39-S70."
    },
    {
      "type": "text",
      "section": "MICRONUTRIENTS (TRACE ELEMENTS)",
      "line": 250,
      "preview": "Vanek VW et al. Nutr Clin Pract. 2015; 30(4):559-69."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "VITAMIN AND TRACE ELEMENTS LONG-TERM CONSIDERATIONS",
      "line": 252
    },
    {
      "type": "text",
      "section": "VITAMIN AND TRACE ELEMENTS LONG-TERM CONSIDERATIONS",
      "line": 254,
      "preview": "- Multivitamin shortages create the greatest risk for long-term PN patients"
    },
    {
      "type": "text",
      "section": "VITAMIN AND TRACE ELEMENTS LONG-TERM CONSIDERATIONS",
      "line": 255,
      "preview": "- Minimum of 10 mL three times per week"
    },
    {
      "type": "text",
      "section": "VITAMIN AND TRACE ELEMENTS LONG-TERM CONSIDERATIONS",
      "line": 256,
      "preview": "- Use individual vitamins if available"
    },
    {
      "type": "text",
      "section": "VITAMIN AND TRACE ELEMENTS LONG-TERM CONSIDERATIONS",
      "line": 257,
      "preview": "- Thiamine, folic acid, cyanocobalamin"
    },
    {
      "type": "text",
      "section": "VITAMIN AND TRACE ELEMENTS LONG-TERM CONSIDERATIONS",
      "line": 258,
      "preview": "- Oral or enteral vitamin preparations"
    },
    {
      "type": "text",
      "section": "VITAMIN AND TRACE ELEMENTS LONG-TERM CONSIDERATIONS",
      "line": 259,
      "preview": "- Trace elements concerns with commercially available multi-component products"
    },
    {
      "type": "text",
      "section": "VITAMIN AND TRACE ELEMENTS LONG-TERM CONSIDERATIONS",
      "line": 260,
      "preview": "- Manganese toxicity with Parkinson's disease"
    },
    {
      "type": "text",
      "section": "VITAMIN AND TRACE ELEMENTS LONG-TERM CONSIDERATIONS",
      "line": 261,
      "preview": "- Copper deposition in liver with possible Wilson's disease"
    },
    {
      "type": "text",
      "section": "VITAMIN AND TRACE ELEMENTS LONG-TERM CONSIDERATIONS",
      "line": 262,
      "preview": "- If trace elements are removed for worsening hepatic disease"
    },
    {
      "type": "text",
      "section": "VITAMIN AND TRACE ELEMENTS LONG-TERM CONSIDERATIONS",
      "line": 263,
      "preview": "- Reassess after 4 weeks (Serum monitoring in select patients)"
    },
    {
      "type": "text",
      "section": "VITAMIN AND TRACE ELEMENTS LONG-TERM CONSIDERATIONS",
      "line": 265,
      "preview": "--- page 11 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF-ASSESSMENT \\#2",
      "line": 267
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 269,
      "preview": "RC is a malnourished 52-year-old male with a postoperative ileus on hospital day 3. His weight is 60"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 271,
      "preview": "How would you determine his PN goal and initiation?"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "HOW TO WRITE A PN ORDER",
      "line": 273
    },
    {
      "type": "text",
      "section": "HOW TO WRITE A PN ORDER",
      "line": 275,
      "preview": "- Step 1 - What is your dosing weight? 60 kg"
    },
    {
      "type": "text",
      "section": "HOW TO WRITE A PN ORDER",
      "line": 276,
      "preview": "- Step 2 - How much protein is needed? $1.5 \\mathrm{~g} / \\mathrm{kg} /$ day"
    },
    {
      "type": "text",
      "section": "HOW TO WRITE A PN ORDER",
      "line": 277,
      "preview": "- Step 3 - How many calories are needed? $25 \\mathrm{kcal} / \\mathrm{kg} /$ day"
    },
    {
      "type": "text",
      "section": "HOW TO WRITE A PN ORDER",
      "line": 278,
      "preview": "- Step 4 - What is your volume limit? $2100 \\mathrm{~mL} /$ day"
    },
    {
      "type": "text",
      "section": "HOW TO WRITE A PN ORDER",
      "line": 279,
      "preview": "- Step 5 - Is the patient malnourished or NPO > 7 days? Yes"
    },
    {
      "type": "text",
      "section": "HOW TO WRITE A PN ORDER",
      "line": 280,
      "preview": "- Step 6 - Any electrolyte disorders present? Yes"
    },
    {
      "type": "text",
      "section": "HOW TO WRITE A PN ORDER",
      "line": 281,
      "preview": "- Step 7 - Is renal function normal? Yes"
    },
    {
      "type": "text",
      "section": "HOW TO WRITE A PN ORDER",
      "line": 282,
      "preview": "- Step 8 - What electrolyte dosages are needed?"
    },
    {
      "type": "text",
      "section": "HOW TO WRITE A PN ORDER",
      "line": 283,
      "preview": "- Step 9 - What other items should be added?"
    },
    {
      "type": "text",
      "section": "HOW TO WRITE A PN ORDER",
      "line": 284,
      "preview": "- Step 10 - Can the current PN be administered peripherally or centrally?"
    },
    {
      "type": "text",
      "section": "HOW TO WRITE A PN ORDER",
      "line": 285,
      "preview": "- Step 11 - When should the PN be advanced to goal?"
    },
    {
      "type": "text",
      "section": "HOW TO WRITE A PN ORDER",
      "line": 287,
      "preview": "--- page 12 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "PN ORDER STEP 2",
      "line": 289
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 2",
      "line": 291,
      "preview": "- Step 2 - How much protein is needed?"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 2",
      "line": 292,
      "preview": "- Daily protein requirement"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 2",
      "line": 293,
      "preview": "- Minimum: $0.8 \\mathrm{~g} / \\mathrm{kg} /$ day"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 2",
      "line": 294,
      "preview": "- Stable: $0.8-1 \\mathrm{~g} / \\mathrm{kg} /$ day"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 2",
      "line": 295,
      "preview": "- Critically ill: $1.2-2 \\mathrm{~g} / \\mathrm{kg} /$ day"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 2",
      "line": 296,
      "preview": "- Obesity: 2 - 2.5 g IBW/kg/day"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 2",
      "line": 297,
      "preview": "- ( 1.5 g Protein $/ \\mathrm{kg} /$ day (post-operative) $\\times 60 \\mathrm{~kg})=90 \\mathrm{~g}$ Pr"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 2",
      "line": 298,
      "preview": "- $(90 \\mathrm{~g}$ Protein $\\times 4 \\mathrm{kcal} / \\mathrm{g})=360 \\mathrm{kcal} /$ day"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 2",
      "line": 299,
      "preview": "- Stock Amino Acids $10 \\%=10 \\mathrm{~g} / 100 \\mathrm{~mL}=100 \\mathrm{~g} / 1000 \\mathrm{~mL}$"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 2",
      "line": 300,
      "preview": "- 90 g Protein $=900 \\mathrm{~mL}$ Stock Amino Acids $10 \\%$"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "PN ORDER STEP 3",
      "line": 303
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3",
      "line": 305,
      "preview": "- Step 3 - How many calories are needed?"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3",
      "line": 306,
      "preview": "- Daily total caloric requirement"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3",
      "line": 307,
      "preview": "$-20-30 \\mathrm{kcal} / \\mathrm{kg} /$ day $\\times 60 \\mathrm{~kg}=1200-1800 \\mathrm{kcal} /$ day"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3",
      "line": 308,
      "preview": "- $1500 \\mathrm{kcal} /$ day is our selection"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3",
      "line": 309,
      "preview": "- ( 4 g Dextrose $/ \\mathrm{kg} /$ day $\\times 60 \\mathrm{~kg})=240 \\mathrm{~g}$ Dextrose/day"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3",
      "line": 310,
      "preview": "- $((240 \\mathrm{~g}$ Dextrose/day $\\div 60 \\mathrm{~kg}) \\times 1000 \\mathrm{mg} / \\mathrm{g}) \\div"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3",
      "line": 311,
      "preview": "- $(240 \\mathrm{~g}$ Dextrose $\\times 3.4 \\mathrm{kcal} / \\mathrm{g})=816 \\mathrm{kcal} /$ day"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3",
      "line": 312,
      "preview": "- Stock Dextrose $70 \\%=70 \\mathrm{~g} / 100 \\mathrm{~mL}=700 \\mathrm{~g} / 1000 \\mathrm{~mL}$"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3",
      "line": 313,
      "preview": "- 240 g Dextrose $=342 \\mathrm{~mL}$ Stock Dextrose $70 \\%$"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3",
      "line": 315,
      "preview": "--- page 13 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "PN ORDER STEP 3, CONT.",
      "line": 317
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3, CONT.",
      "line": 319,
      "preview": "- Step 3 - How many calories are needed?"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3, CONT.",
      "line": 320,
      "preview": "- Daily total caloric requirement"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3, CONT.",
      "line": 321,
      "preview": "- (1500 kcal/day (our selection) - 816 kcal Dextrose/day) $=684 \\mathrm{kcal} /$ day"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3, CONT.",
      "line": 322,
      "preview": "- (684 kcal/day - 360 kcal Protein/day) $=324 \\mathrm{kcal} /$ day as ILE"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3, CONT.",
      "line": 323,
      "preview": "- (324 kcal/day $\\div 10 \\mathrm{kcal} / \\mathrm{g}(20 \\% \\mathrm{ILE}))=32 \\mathrm{~g}$ ILE/day"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3, CONT.",
      "line": 324,
      "preview": "- Stock 20\\% ILE $=20 \\mathrm{~g} / 100 \\mathrm{~mL}$"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3, CONT.",
      "line": 325,
      "preview": "- 32 g ILE/day $=160 \\mathrm{~mL}$ Stock 20\\% ILE"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3, CONT.",
      "line": 326,
      "preview": "- 816 kcal Dextrose +360 kcal Protein +320 kcal ILE $=1496 \\mathrm{kcal} /$ day"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 3, CONT.",
      "line": 327,
      "preview": "- $25 \\mathrm{kcal} / \\mathrm{kg} /$ day based upon dosing weight of 60 kg"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "PN ORDER STEP 4",
      "line": 330
    },
    {
      "type": "image",
      "section": "PN ORDER STEP 4",
      "line": 332,
      "content": "![img-6.jpeg](images/9329333f7e9bfc9f.png)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 4",
      "line": 334,
      "preview": "- Step 4 - What is your volume limit?"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 4",
      "line": 335,
      "preview": "- Daily volume estimation"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 4",
      "line": 336,
      "preview": "- Age and weight based"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 4",
      "line": 338,
      "preview": "Most adults (18-55 yrs) ( $35 \\mathrm{~mL} / \\mathrm{kg} /$ day $\\times 60 \\mathrm{~kg})=2100 \\mathr"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 4",
      "line": 340,
      "preview": "- [2100 mL/day (our selection) - ( 900 mL Stock Amino Acids 10\\% + 342 mL Stock Dextrose $70 \\%+160 "
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 4",
      "line": 341,
      "preview": "- Therefore, add 698 mL of Sterile Water for Injection for a total volume of $2100 \\mathrm{~mL} /$ d"
    },
    {
      "type": "table",
      "section": "PN ORDER STEP 4",
      "line": 343,
      "preview": "| Final Amino Acid 4.3\\% |"
    },
    {
      "type": "table",
      "section": "PN ORDER STEP 4",
      "line": 344,
      "preview": "| :-- |"
    },
    {
      "type": "table",
      "section": "PN ORDER STEP 4",
      "line": 345,
      "preview": "| Final Dextrose 11.4\\% |"
    },
    {
      "type": "table",
      "section": "PN ORDER STEP 4",
      "line": 346,
      "preview": "| Final ILE 1.5\\% |"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 4",
      "line": 348,
      "preview": "--- page 14 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "PN ORDER STEP 4, CONT.",
      "line": 350
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 4, CONT.",
      "line": 352,
      "preview": "- Not stable as a 3-in-1, also known as a total nutrient admixture"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 4, CONT.",
      "line": 353,
      "preview": "- Ideally final amino acid $\\geq 4 \\%+$ dextrose $\\geq 10 \\%+$ ILE $\\geq 2 \\%$"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 4, CONT.",
      "line": 354,
      "preview": "- Change dose of ILE to 50 g to meet above recommendations ( $1676 \\mathrm{kcal} /$ day $)$"
    },
    {
      "type": "table",
      "section": "PN ORDER STEP 4, CONT.",
      "line": 356,
      "preview": "| Final Amino Acid 4.3\\% |"
    },
    {
      "type": "table",
      "section": "PN ORDER STEP 4, CONT.",
      "line": 357,
      "preview": "| :-- |"
    },
    {
      "type": "table",
      "section": "PN ORDER STEP 4, CONT.",
      "line": 358,
      "preview": "| Final Dextrose 11.4\\% |"
    },
    {
      "type": "table",
      "section": "PN ORDER STEP 4, CONT.",
      "line": 359,
      "preview": "| Final ILE 2.4\\% |"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 4, CONT.",
      "line": 361,
      "preview": "- May alternatively use PN formulation without sterile water for injection only adding amino acids, "
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 4, CONT.",
      "line": 362,
      "preview": "- IV fluids may be infusing for other IV medications (e.g., patient controlled analgesia, antimicrob"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "PN ORDER STEP 5",
      "line": 365
    },
    {
      "type": "image",
      "section": "PN ORDER STEP 5",
      "line": 367,
      "content": "![img-7.jpeg](images/9329333f7e9bfc9f.png)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 5",
      "line": 369,
      "preview": "- Step 5 - Is the patient malnourished or NPO $>7$ days?"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 5",
      "line": 370,
      "preview": "- Yes"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 5",
      "line": 371,
      "preview": "- Start with 2 g Dextrose $/ \\mathrm{kg} /$ day to prevent refeeding and assess glucose tolerance"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 5",
      "line": 372,
      "preview": "- 120 g Dextrose/day $=171 \\mathrm{~mL}$ Stock Dextrose $70 \\%$"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 5",
      "line": 373,
      "preview": "- No"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 5",
      "line": 374,
      "preview": "- Start with 3 g Dextrose/kg/day to assess glucose tolerance"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 5",
      "line": 375,
      "preview": "- 180 g Dextrose/day $=257 \\mathrm{~mL}$ Stock Dextrose $70 \\%$"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 5",
      "line": 376,
      "preview": "- Begin 1 g Protein/kg/day with either of the above"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 5",
      "line": 377,
      "preview": "- (1 g Protein/kg/day (post-operative) $\\times 60 \\mathrm{~kg}$ ) $=60 \\mathrm{~g}$ Protein/day"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 5",
      "line": 379,
      "preview": "--- page 15 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 381
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 383,
      "preview": "- Day 1 Malnourished PN regimen"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 384,
      "preview": "- PN Volume $=2100 \\mathrm{~mL} /$ day"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 385,
      "preview": "- 600 mL Stock Amino Acids 10\\%"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 386,
      "preview": "- 171 mL Stock Dextrose 70\\%"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 387,
      "preview": "- 1329 mL Sterile Water for Injection"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 388,
      "preview": "- 240 kcal from Protein +407 kcal from Dextrose $=648 \\mathrm{kcal} /$ day"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 389,
      "preview": "- Step 6 - Any electrolyte disorders present?"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 390,
      "preview": "- Yes"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 391,
      "preview": "- Potassium $3.2 \\mathrm{mEq} / \\mathrm{L}$, Phosphorus $2.5 \\mathrm{mg} / \\mathrm{dL}$, Magnesium $"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 392,
      "preview": "- Step 7 - Is renal function normal?"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 393,
      "preview": "- Yes"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 394,
      "preview": "- Serum creatinine $0.9 \\mathrm{mg} / \\mathrm{dL}$"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 396,
      "preview": "Final Amino Acid 2.9\\%"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 397,
      "preview": "Final Dextrose 5.7\\%"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 398,
      "preview": "- Step 8 - What electrolyte dosages are needed?"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 400,
      "preview": "- Sodium 1-2 mEq/kg $\\times 60 \\mathrm{~kg}=60-120 \\mathrm{mEq} /$ day"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 401,
      "preview": "- Select 120 mEq (wide therapeutic index)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 402,
      "preview": "- 57 mEq Sodium/L of current PN (2.1 L)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 403,
      "preview": "- Phosphate 20-40 mmol* (wide therapeutic index)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 404,
      "preview": "- Select $40 \\mathrm{mmol} /$ day as Potassium Phosphate $=59 \\mathrm{mEq}$ of Potassium/day"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 405,
      "preview": "- Approximately 19 mmol Phosphate/L of current PN (2.1 L)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 406,
      "preview": "* Based on compatibility limits with calcium"
    },
    {
      "type": "text",
      "section": "PN ORDER STEPS 6 \\& 7",
      "line": 408,
      "preview": "--- page 16 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "PN ORDER STEP 8, CONT.",
      "line": 410
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 412,
      "preview": "- Step 8 - What electrolyte dosages are needed?"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 413,
      "preview": "- Potassium 1-2 mEq/kg $\\times 60 \\mathrm{~kg}=60-120 \\mathrm{mEq} /$ day (narrow therapeutic index)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 414,
      "preview": "- Select 90 mEq /day - potassium contribution from Potassium Phosphate"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 415,
      "preview": "- Therefore, add 30 mEq Potassium Chloride/day for a total of 89 mEq"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 416,
      "preview": "- 42 mEq Potassium/L of current PN (2.1 L)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 417,
      "preview": "- Magnesium 8-20 mEq"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 418,
      "preview": "- Select 20 mEq/day (wide therapeutic index)"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "PN ORDER STEP 8, CONT.",
      "line": 421
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 423,
      "preview": "- Step 8 - What electrolyte dosages are needed? Calcium 10-15 mEq*"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 424,
      "preview": "- Select 10 mEq of Calcium Gluconate"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 425,
      "preview": "- Approximately 4.8 mEq Calcium/L of current PN (2.1 L)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 426,
      "preview": "- Check manufacturer information for compatibility"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 427,
      "preview": "- Unable to add dose based upon graphs on next slide"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 428,
      "preview": "* Based on compatibility limits with calcium"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 430,
      "preview": "--- page 17 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "PN ORDER STEP 8, CONT.",
      "line": 432
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 434,
      "preview": "- Determine appropriate compatibility curve for the brand of amino acids"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 436,
      "preview": "1. Final PN volume (L)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 437,
      "preview": "2. Final amino acid concentration (\\%)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 438,
      "preview": "3. Final dextrose concentration (\\%)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 439,
      "preview": "4. Final calcium gluconate concentration (mEq/L)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 440,
      "preview": "5. Final phosphate concentration (mmol/L)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 441,
      "preview": "6. Select the most appropriate curve (use most conservative estimate)"
    },
    {
      "type": "image",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 442,
      "content": "![img-8.jpeg](images/b99e493308c2b67c.png)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 8, CONT.",
      "line": 444,
      "preview": "Higher concentrations of amino acids and dextrose improve solubility of calciumphosphate"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "PN ORDER STEP 9",
      "line": 446
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 9",
      "line": 448,
      "preview": "- Step 9 - What other items should be added?"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 9",
      "line": 449,
      "preview": "- Multivitamins (consider adding additional thiamine)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 9",
      "line": 450,
      "preview": "- Trace Elements (zinc, copper, selenium, manganese)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 9",
      "line": 451,
      "preview": "- $\\mathrm{H}_{2}$ antagonist (ranitidine, famotidine)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 9",
      "line": 452,
      "preview": "- Regular Human Insulin"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 9",
      "line": 453,
      "preview": "- What is the baseline serum glucose?"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 9",
      "line": 454,
      "preview": "- Should insulin be added initially?"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 9",
      "line": 455,
      "preview": "- Only if serum glucoses dictate ( $>180 \\mathrm{mg} / \\mathrm{dL}$ )"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 9",
      "line": 456,
      "preview": "- How much with 120 g Dextrose/day in current PN?"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 9",
      "line": 457,
      "preview": "- 12 units Regular Insulin is 1 unit Insulin for every 10 g of Dextrose"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 9",
      "line": 459,
      "preview": "--- page 18 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "PN ORDER STEP 10",
      "line": 461
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 463,
      "preview": "- Step 10 - Can the current PN be administered peripherally or centrally?"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 464,
      "preview": "- Final Concentrations = Dextrose 5.7\\%, Amino Acids 2.9\\%"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 466,
      "preview": "Dextrose $5.7 \\% \\times 50=$"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 467,
      "preview": "285 mOsm/L"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 468,
      "preview": "Amino Acids $2.9 \\% \\times 100=$"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 469,
      "preview": "290 mOsm/L"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 470,
      "preview": "Electrolytes (1 per mEq) $=$"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 471,
      "preview": "229 mOsm/L"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 472,
      "preview": "Total Osmolarity $=$"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 473,
      "preview": "804 mOsm/L"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 474,
      "preview": "(ILE contributes 15"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 475,
      "preview": "mOsm/Lper 1\\%"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 476,
      "preview": "final concentration when added)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 478,
      "preview": "- Infusion Nurses Society"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 479,
      "preview": "- Maximum osmolarity of 500 mOsm/L for peripheral IV"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 480,
      "preview": "- Nutrition Support literature"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 481,
      "preview": "- Maximum of $900 \\mathrm{mOsm} / \\mathrm{L}$ for peripheral PN"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 482,
      "preview": "- Yes, it can be administered peripherally or centrally"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 10",
      "line": 484,
      "preview": "Mirtallo J et al.JPEN J Parent Enteral Nutr. 2004; 28:S39-S70."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "PN ORDER STEP 11",
      "line": 486
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 11",
      "line": 488,
      "preview": "- Step 11 - When should the PN be advanced to goal?"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 11",
      "line": 489,
      "preview": "- When electrolytes are trending the right way or corrected"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 11",
      "line": 490,
      "preview": "- Potassium, phosphorus, magnesium"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 11",
      "line": 491,
      "preview": "- Sodium may be falsely low from hyperglycemia or hypertriglyceridemia"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 11",
      "line": 492,
      "preview": "- When serum glucoses are consistently $<180 \\mathrm{mg} / \\mathrm{dL}$"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 11",
      "line": 493,
      "preview": "- Generally within 72-96 hours"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 11",
      "line": 494,
      "preview": "- Serum triglycerides are acceptable ( $<400 \\mathrm{mg} / \\mathrm{dL}$ )"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 11",
      "line": 495,
      "preview": "- Separate ILE (based upon bag sizes - 100, 250, 500 mL )"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 11",
      "line": 496,
      "preview": "- Total Nutrient Admixture (requires $\\geq 2 \\%$ final ILE for stability)"
    },
    {
      "type": "text",
      "section": "PN ORDER STEP 11",
      "line": 498,
      "preview": "--- page 19 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "GENERAL GUIDELINES FOR PN INITIATION",
      "line": 500
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION",
      "line": 502,
      "preview": "- Provide at least 1 g protein $/ \\mathrm{kg} /$ day (based on dosing weight) for nitrogen losses re"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION",
      "line": 503,
      "preview": "- Otherwise gluconeogenesis continues to catabolize muscle as an energy source"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION",
      "line": 504,
      "preview": "- Provide at least 2 g dextrose $/ \\mathrm{kg} /$ day (based on dosing weight) for proteinsparing ef"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION",
      "line": 505,
      "preview": "- Evaluate for the addition of at least 1 unit of regular insulin for every 10 grams of dextrose if "
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION",
      "line": 506,
      "preview": "- More conservative insulin dosing may be needed in underweight patients"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION",
      "line": 508,
      "preview": "Doig GS et al. LancetRespir Med. 2015; 3(12):943-52."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 510
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 512,
      "preview": "- If serum phosphorus $<2 \\mathrm{mg} / \\mathrm{dL}$"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 513,
      "preview": "- Start with $480 \\mathrm{kcal} /$ day for at least 2 days"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 514,
      "preview": "- Then $960 \\mathrm{kcal} /$ day for 1 day"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 515,
      "preview": "- Then $1440 \\mathrm{kcal} /$ day or $80 \\%$ of energy goal (whichever is lower) for 1 day"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 516,
      "preview": "- Then $100 \\%$ of energy goal until serum electrolytes and glucoses are stabilized"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 518,
      "preview": "--- page 20 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 520
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 522,
      "preview": "- For adult patients with normal renal function ( $\\mathrm{CrCl}>50 \\mathrm{~mL} / \\mathrm{min}$ ), "
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 523,
      "preview": "- Sodium $80 \\mathrm{mEq} / \\mathrm{L}$ based on fluid needs \\& losses from tubes, drains, etc."
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 524,
      "preview": "- Potassium $1 \\mathrm{mEq} / \\mathrm{kg}$ (based on dosing weight)"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 525,
      "preview": "- Presence of metabolic acidosis or use of medications resulting in potassium retention will also af"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 526,
      "preview": "- Magnesium $8-20 \\mathrm{mEq}$"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 527,
      "preview": "- Phosphate $20-40 \\mathrm{mmol}$"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 528,
      "preview": "- Assess need for calcium gluconate with above dosage of phosphate given compatibility limits of ami"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 530,
      "preview": "Mirtallo J et al.JPEN J ParentEnteral Nutr. 2004; 28:S39-S70."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 532
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 534,
      "preview": "- For patients with normal renal function ( CrCl greater than $50 \\mathrm{~mL} / \\mathrm{min}$ ), th"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 535,
      "preview": "- Use of chloride-based salts (all commercially available amino acids solutions are acetate-based)"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 536,
      "preview": "- Use acetate-based salts if metabolic acidosis present"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 537,
      "preview": "- Anticipate effects of refeeding syndrome and drug-nutrient interactions based upon patient history"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 538,
      "preview": "- Consider additional thiamine initially for severely malnourished"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 539,
      "preview": "- Order daily basic metabolic panel, serum phosphorus, magnesium and total calcium for at least 2-3 "
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 540,
      "preview": "- Consider ionized calcium if total calcium is $<7 \\mathrm{mg} / \\mathrm{dL}$"
    },
    {
      "type": "text",
      "section": "GENERAL GUIDELINES FOR PN INITIATION, CONT.",
      "line": 542,
      "preview": "--- page 21 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "CONCLUSIONS",
      "line": 544
    },
    {
      "type": "text",
      "section": "CONCLUSIONS",
      "line": 546,
      "preview": "- Primary goal of nutrition support is to provide the required amounts of nitrogen (protein) and ene"
    },
    {
      "type": "text",
      "section": "CONCLUSIONS",
      "line": 547,
      "preview": "- Electrolyte requirements are dependent on patient age, renal function, drugnutrient interactions a"
    },
    {
      "type": "text",
      "section": "CONCLUSIONS",
      "line": 548,
      "preview": "- Oral or enteral route is preferred (if available) due to safety concerns compared to IV administra"
    },
    {
      "type": "text",
      "section": "CONCLUSIONS",
      "line": 549,
      "preview": "- Multivitamins and trace elements (e.g., Zinc, Selenium, Copper) are necessary requirements in all "
    },
    {
      "type": "text",
      "section": "CONCLUSIONS",
      "line": 550,
      "preview": "- Reviewing PN orders for adequacy and efficacy are required daily"
    },
    {
      "type": "text",
      "section": "CONCLUSIONS",
      "line": 551,
      "preview": "- Including the determination of osmolarity"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "REFERENCES",
      "line": 554
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 556,
      "preview": "- Boullata JI, Gilbert K, Sacks G et al. A.S.P.E.N. clinical guidelines: Parenteral nutrition orderi"
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 557,
      "preview": "- Canada TW, Lord LM. Chapter 7 Fluid, Electrolytes, and Acid-Base Disorders. In: Mueller CM, ed. Th"
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 558,
      "preview": "- Doig GS, Simpson F, Heighes PT et al. Restricted versus continued standard caloric intake during t"
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 559,
      "preview": "- Mirtallo J, Canada T, Johnson D et al. Safe practices for parenteral nutrition. JPEN J Parent Ente"
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 561,
      "preview": "--- page 22 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "REFERENCES, CONT.",
      "line": 563
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 565,
      "preview": "- Mundi MS, Nystrom EM, Hurley DL et al. Management of parenteral nutrition in hospitalized adult pa"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 566,
      "preview": "- Schmidt GL. Techniques and procedures: Guidelines for managing electrolytes in total parenteral nu"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 567,
      "preview": "- Vanek VW, Borum P, Buchman A et al. A call to action to bring safer parenteral micronutrient produ"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 569,
      "preview": "--- page 23 ---"
    },
    {
      "type": "image",
      "section": "REFERENCES, CONT.",
      "line": 571,
      "content": "![img-9.jpeg](images/f88d6ef789286d4c.png)"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Todd W. Canada, Pharm.D., BCNSP, BCCCP, FASHP, FTSHP, FASPEN",
      "line": 573
    },
    {
      "type": "text",
      "section": "Todd W. Canada, Pharm.D., BCNSP, BCCCP, FASHP, FTSHP, FASPEN",
      "line": 575,
      "preview": "Clinical Pharmacy Services Manager"
    },
    {
      "type": "text",
      "section": "Todd W. Canada, Pharm.D., BCNSP, BCCCP, FASHP, FTSHP, FASPEN",
      "line": 576,
      "preview": "Nutrition Support Team Coordinator"
    },
    {
      "type": "text",
      "section": "Todd W. Canada, Pharm.D., BCNSP, BCCCP, FASHP, FTSHP, FASPEN",
      "line": 577,
      "preview": "University of Texas MD Anderson Cancer Center"
    },
    {
      "type": "text",
      "section": "Todd W. Canada, Pharm.D., BCNSP, BCCCP, FASHP, FTSHP, FASPEN",
      "line": 578,
      "preview": "Houston, Texas"
    },
    {
      "type": "text",
      "section": "Todd W. Canada, Pharm.D., BCNSP, BCCCP, FASHP, FTSHP, FASPEN",
      "line": 579,
      "preview": "Todd W. Canada serves as a clinical pharmacy services manager and nutrition support team coordinator"
    },
    {
      "type": "text",
      "section": "Todd W. Canada, Pharm.D., BCNSP, BCCCP, FASHP, FTSHP, FASPEN",
      "line": 581,
      "preview": "Dr. Canada completed a specialized residency in Critical Care / Nutrition Support at the University "
    },
    {
      "type": "text",
      "section": "Todd W. Canada, Pharm.D., BCNSP, BCCCP, FASHP, FTSHP, FASPEN",
      "line": 583,
      "preview": "--- page 24 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Relevant Financial Relationship Disclosure",
      "line": 585
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 587,
      "preview": "In accordance with our accreditor\u2019s Standards of Integrity and Independence in Accredited Continuing"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 589,
      "preview": "An ineligible company is any entity producing, marketing, re-selling, or distributing health care go"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 591,
      "preview": "The following persons in control of this activity\u2019s content have relevant financial relationships:"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 593,
      "preview": "- Phil Ayers: Fresenius Kabi, consultant and speaker"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 594,
      "preview": "- David Evans: Fresenius Kabi, consultant and speaker; Abbott Laboratories, consultant and speaker; "
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 595,
      "preview": "- Andrew Mays: Fresenius Kabi, speaker"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 596,
      "preview": "- Jay Mirtallo: Fresenius Kabi, consultant"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 597,
      "preview": "- Kris Mogensen: Baxter, speaker; ThriveRx, advisory board; Pfizer, advisory board"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 599,
      "preview": "All other persons in control of content do not have any relevant financial relationships with an ine"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 601,
      "preview": "As required by the Standards of Integrity and Independence in Accredited Continuing Education defini"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Methods and CE Requirements",
      "line": 603
    },
    {
      "type": "text",
      "section": "Methods and CE Requirements",
      "line": 605,
      "preview": "This online activity consists of a combined total of 12 learning modules. Pharmacists and physicians"
    },
    {
      "type": "text",
      "section": "Methods and CE Requirements",
      "line": 607,
      "preview": "Participants must participate in the entire activity, complete the evaluation and all required compo"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Important Note \u2013 ACPE 60 Day Deadline:",
      "line": 609
    },
    {
      "type": "text",
      "section": "Important Note \u2013 ACPE 60 Day Deadline:",
      "line": 611,
      "preview": "Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "System Technical Requirements",
      "line": 613
    },
    {
      "type": "text",
      "section": "System Technical Requirements",
      "line": 615,
      "preview": "Courses and learning activities are delivered via your Web browser and Acrobat PDF. Users should hav"
    },
    {
      "type": "text",
      "section": "System Technical Requirements",
      "line": 617,
      "preview": "View Frequently Asked Questions for more information."
    }
  ],
  "images": [
    {
      "sha_name": "9c01a79eee8ab186.png",
      "original_ref": "img-0.jpeg",
      "page": 1,
      "relative_path": "images/9c01a79eee8ab186.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/2_NutritionalRequirements,Part2/images/9c01a79eee8ab186.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "9c01a79eee8ab186"
    },
    {
      "sha_name": "95661183b74a919d.png",
      "original_ref": "img-1.jpeg",
      "page": 1,
      "relative_path": "images/95661183b74a919d.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/2_NutritionalRequirements,Part2/images/95661183b74a919d.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "95661183b74a919d"
    },
    {
      "sha_name": "4f56eb7ebda1a0dd.png",
      "original_ref": "img-2.jpeg",
      "page": 5,
      "relative_path": "images/4f56eb7ebda1a0dd.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/2_NutritionalRequirements,Part2/images/4f56eb7ebda1a0dd.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "4f56eb7ebda1a0dd"
    },
    {
      "sha_name": "09f4109c6384fe18.png",
      "original_ref": "img-3.jpeg",
      "page": 5,
      "relative_path": "images/09f4109c6384fe18.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/2_NutritionalRequirements,Part2/images/09f4109c6384fe18.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "09f4109c6384fe18"
    },
    {
      "sha_name": "13d1966887faa978.png",
      "original_ref": "img-4.jpeg",
      "page": 6,
      "relative_path": "images/13d1966887faa978.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/2_NutritionalRequirements,Part2/images/13d1966887faa978.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "13d1966887faa978"
    },
    {
      "sha_name": "0f112e7542ef57b2.png",
      "original_ref": "img-5.jpeg",
      "page": 6,
      "relative_path": "images/0f112e7542ef57b2.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/2_NutritionalRequirements,Part2/images/0f112e7542ef57b2.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "0f112e7542ef57b2"
    },
    {
      "sha_name": "9329333f7e9bfc9f.png",
      "original_ref": "img-6.jpeg",
      "page": 13,
      "relative_path": "images/9329333f7e9bfc9f.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/2_NutritionalRequirements,Part2/images/9329333f7e9bfc9f.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "9329333f7e9bfc9f"
    },
    {
      "sha_name": "9329333f7e9bfc9f.png",
      "original_ref": "img-7.jpeg",
      "page": 14,
      "relative_path": "images/9329333f7e9bfc9f.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/2_NutritionalRequirements,Part2/images/9329333f7e9bfc9f.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "9329333f7e9bfc9f"
    },
    {
      "sha_name": "b99e493308c2b67c.png",
      "original_ref": "img-8.jpeg",
      "page": 17,
      "relative_path": "images/b99e493308c2b67c.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/2_NutritionalRequirements,Part2/images/b99e493308c2b67c.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "b99e493308c2b67c"
    },
    {
      "sha_name": "f88d6ef789286d4c.png",
      "original_ref": "img-9.jpeg",
      "page": 23,
      "relative_path": "images/f88d6ef789286d4c.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/2_NutritionalRequirements,Part2/images/f88d6ef789286d4c.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "f88d6ef789286d4c"
    }
  ],
  "extraction": {
    "ocr_model": "mistral-ocr-latest",
    "request_id": "local-1754695946",
    "ts": "2025-08-08T23:32:26.679414+00:00"
  }
}